{"id":"https://genegraph.clinicalgenome.org/r/1c7827fe-dbd8-4b5a-9220-6a88f2d3cdc2v1.0","type":"EvidenceStrengthAssertion","dc:description":"JAG2 encodes jagged canonical Notch ligand 2, one of several ligands that activate Notch and related receptors. JAG2 was first reported in relation to autosomal recessive limb girdle muscular dystrophy in 2021 (Coppens et al., PMID: 33861953). Among the 27 patients from 16 families described to date, symptom onset ranges from infancy to adolescence/young adulthood. Muscle weakness is typically progressive with lower extremity and proximal dominance; loss of ambulation occurs in a subset of individuals. Reduced or absent deep tendon reflexes are common, and serum CK is normal or mildly elevated. Muscle biopsy findings are primarily dystrophic but may also include myopathic features. Additional features observed in some patients include scoliosis, joint contractures, ptosis and mild facial weakness, muscle atrophy or hypertrophy, cardiac features, asymptomatic moderate respiratory muscle weakness, intellectual disability or global developmental delay, speech delay, and autism spectrum disorder. Eighteen variants (13 missense, 1 in-frame indel, 1 nonsense, 2 frameshift, and 1 large deletion) reported in 16 probands in three publications (PMID: 33861953, 34878394, 39121631) are included in this curation. Co-segregation of JAG2 variants in affected family members was observed in multiple families, including three with at least three affected individuals. The mechanism of pathogenicity appears to be loss of function. However, additional investigation is needed as the effects of missense variants on gene function have not yet been determined, and many missense variants were identified in a homozygous state, often in consanguineous families. This gene-disease relationship is also supported by experimental evidence, including altered Notch pathway gene expression in patient muscle tissue and murine myoblasts following shRNA-mediated JAG2 knockdown as well as age-related locomotor decline in Drosophila following RNAi-mediated downregulation of Serrate (JAG2 ortholog)-dependent Notch signaling in adult muscle progenitors (PMID: 33861953, 39121631). In summary, there is moderate evidence supporting the relationship between JAG2 and autosomal recessive limb girdle muscular dystrophy. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Muscular Dystrophies and Myopathies GCEP on August 13, 2024 (SOP Version 10).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/1c7827fe-dbd8-4b5a-9220-6a88f2d3cdc2","GCISnapshot":"https://genegraph.clinicalgenome.org/r/16f43ce9-05b5-437d-a35e-b1c379c0ba7a","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/16f43ce9-05b5-437d-a35e-b1c379c0ba7a_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10151","date":"2024-08-27T18:42:34.932Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/16f43ce9-05b5-437d-a35e-b1c379c0ba7a_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10151","date":"2024-08-27T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16f43ce9-05b5-437d-a35e-b1c379c0ba7a_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16f43ce9-05b5-437d-a35e-b1c379c0ba7a_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5dc90d7-77fa-45bf-bd55-f0b925b437ae_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family GER","estimatedLodScore":1.33,"family":{"id":"https://genegraph.clinicalgenome.org/r/e5dc90d7-77fa-45bf-bd55-f0b925b437ae","type":"Family","rdfs:label":"Coppens 2021 Family GER","member":{"id":"https://genegraph.clinicalgenome.org/r/b32f21b3-74bd-4ff6-aac8-95c8f4b6f921","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family GER, individual II.1 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":38,"allele":{"id":"https://genegraph.clinicalgenome.org/r/88058778-b248-462a-ada4-d38186cb41c7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.2134C>T (p.Arg712Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391267925"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Childhood onset, rapid progress, loss of ambulation at 9 years, contractures, mild facial weakness, mild neck weakness, scoliosis, rigid spine/neck, 41% FVC, normal CK, myopathic EMG, dystrophic muscle biopsy\n","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d69788bd-0a21-41bb-9a9a-4a382f445ecb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/88058778-b248-462a-ada4-d38186cb41c7"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/b32f21b3-74bd-4ff6-aac8-95c8f4b6f921"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/dad23101-820c-4a14-aeeb-aec4a3697d23_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family EGY","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/dad23101-820c-4a14-aeeb-aec4a3697d23","type":"Family","rdfs:label":"Coppens 2021 Family EGY","member":{"id":"https://genegraph.clinicalgenome.org/r/513045c7-102a-45c3-9d14-67a0afeda6c0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family EGY, individual II.1 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":27,"allele":{"id":"https://genegraph.clinicalgenome.org/r/12f11321-079f-4e42-9636-ed7ef36b8094","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.1073A>T (p.Asn358Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391273513"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Adolescent onset, slow progression, contractures, normal FVC, normal CK, myopathic EMG\n","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8f1d60f5-3778-4119-aa8d-7b120b5d278b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/12f11321-079f-4e42-9636-ed7ef36b8094"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/513045c7-102a-45c3-9d14-67a0afeda6c0"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/3cf0bdac-7b1c-489b-8907-f8dad5ffb511_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family POL","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/3cf0bdac-7b1c-489b-8907-f8dad5ffb511","type":"Family","rdfs:label":"Coppens 2021 Family POL","member":{"id":"https://genegraph.clinicalgenome.org/r/ddf77182-44e3-4c88-a48f-5d89a8e46273","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family POL, individual II.3 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":53,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1be6710f-f84d-4445-ab32-b841a1808d6e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.2515G>A (p.Gly839Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7385558"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Young adult onset, slow progression, ptosis, moderate neck weakness, 66% FVC, normal CK, myopathic EMG\n","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5acb5d42-08b4-4a5f-bc29-c3067af71fd3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/1be6710f-f84d-4445-ab32-b841a1808d6e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":3,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ddf77182-44e3-4c88-a48f-5d89a8e46273"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1032e87e-049a-43ef-b410-84a8729a78d7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bb77647-a2f9-4eb7-9654-f06b45ed0641","type":"EvidenceLine","dc:description":"missense, no functional data","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bb77647-a2f9-4eb7-9654-f06b45ed0641_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in EGF1 domain; protein destabilization predicted by structural modeling; Revel 0.38\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/7bb77647-a2f9-4eb7-9654-f06b45ed0641_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/1e4d4a63-d1f4-4393-8270-c9b50a6771cd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.728C>A (p.Ala243Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA267399171"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/1032e87e-049a-43ef-b410-84a8729a78d7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family BEL, individual II.1 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1e4d4a63-d1f4-4393-8270-c9b50a6771cd"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Infant onset, rapid progression, loss of ambulation at 8 years, contractures, mild facial weakness, severe neck weakness, scoliosis, FVC 57%, moderate ID, CK 1.3xULN, myopathic EMG, dystrophic muscle biopsy\n","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7bb77647-a2f9-4eb7-9654-f06b45ed0641_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/f7e5ceb6-8e53-4501-bcda-56a26510eef7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd153f75-b7d9-45e1-b9df-5d1778e20902","type":"EvidenceLine","dc:description":"missense, no functional data","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd153f75-b7d9-45e1-b9df-5d1778e20902_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in EGF3 domain in region involved in disulphide bonding; Revel 0.91","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/cd153f75-b7d9-45e1-b9df-5d1778e20902_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39121631","allele":{"id":"https://genegraph.clinicalgenome.org/r/0b91aebc-9f4c-4172-acde-00965a8f0c40","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.1021G>T (p.Gly341Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391273786"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/f7e5ceb6-8e53-4501-bcda-56a26510eef7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39121631","rdfs:label":"Dofash 2024 Family 1, individual II:2 ","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":5,"allele":{"id":"https://genegraph.clinicalgenome.org/r/0b91aebc-9f4c-4172-acde-00965a8f0c40"},"detectionMethod":"trio WES","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Severe progressive muscle weakness, motor delay, axial and proximal lower limb weakness, reduced reflexes, normal serum CK, dystrophic muscle MRI","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cd153f75-b7d9-45e1-b9df-5d1778e20902_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/b32f21b3-74bd-4ff6-aac8-95c8f4b6f921_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d69788bd-0a21-41bb-9a9a-4a382f445ecb","type":"EvidenceLine","dc:description":"missense, no functional data","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d69788bd-0a21-41bb-9a9a-4a382f445ecb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in EGF13 domain; Revel 0.69\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/d69788bd-0a21-41bb-9a9a-4a382f445ecb_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/b32f21b3-74bd-4ff6-aac8-95c8f4b6f921"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/36dca3d4-1f59-4b6e-808f-dca1589a30a7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ecb4ec9-6712-4525-bd19-3fb7d0ff3d0a","type":"EvidenceLine","dc:description":"recurrent missense, no functional data","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ecb4ec9-6712-4525-bd19-3fb7d0ff3d0a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in EGF16cb domain; recurrent, at least 2 haplotypes (3 families); Revel 0.92\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/8ecb4ec9-6712-4525-bd19-3fb7d0ff3d0a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/1be6710f-f84d-4445-ab32-b841a1808d6e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8da71fdb-6cc2-4fdd-9c5f-ac77bfe2c483","type":"EvidenceLine","dc:description":"missense, no functional data","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8da71fdb-6cc2-4fdd-9c5f-ac77bfe2c483_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in C2 domain; protein destabilization predicted by structural modeling; Revel 0.76\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/8da71fdb-6cc2-4fdd-9c5f-ac77bfe2c483_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/95961f67-e0dd-4ddf-9fcf-cd3241030230","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.221G>C (p.Cys74Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391173994"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/36dca3d4-1f59-4b6e-808f-dca1589a30a7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family US2, individual II.1 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":25,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/95961f67-e0dd-4ddf-9fcf-cd3241030230"},{"id":"https://genegraph.clinicalgenome.org/r/1be6710f-f84d-4445-ab32-b841a1808d6e"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Adolescent onset, slow progression, mild neck weakness, speech delay, CK 2xULN, myopathic EMG, dystrophic muscle biopsy","previousTesting":false,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8ecb4ec9-6712-4525-bd19-3fb7d0ff3d0a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/8da71fdb-6cc2-4fdd-9c5f-ac77bfe2c483_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/f77cb6c0-c6a3-4b0c-b386-fd6fb45b7c82_proband_score_evidence_line","type":"EvidenceLine","direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e29cdfa1-4f16-4989-bbe8-e8b60c86210e","type":"EvidenceLine","dc:description":"Not scored due to high likelihood of overlap with Coppens et al. case from consanguineous French family homozygous for same variant","calculatedScore":0.2,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e29cdfa1-4f16-4989-bbe8-e8b60c86210e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Not in a domain; Revel 0.52\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/e29cdfa1-4f16-4989-bbe8-e8b60c86210e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34878394","allele":{"id":"https://genegraph.clinicalgenome.org/r/a96df8b3-8385-4db8-9018-d4ce8b8758a8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.2930T>C (p.Phe977Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391264475"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f77cb6c0-c6a3-4b0c-b386-fd6fb45b7c82","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34878394","rdfs:label":"Nur Villar-Quiles 2021 case report","allele":{"id":"https://genegraph.clinicalgenome.org/r/a96df8b3-8385-4db8-9018-d4ce8b8758a8"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Normal early motor development (independent ambulation at 14 mo), childhood onset, axial and proximal weakness, spinal rigidity, contractures, loss of ambulation at 14 years, scoliosis, 55% FVC, normal CK, myogenic EMG, fibrosis and necrosis on muscle biopsy, muscle atrophy and fatty involution on MRI, alpha-dystroglycan deficiency on immunostaining of muscle\n\n","previousTesting":true,"previousTestingDescription":"sequence analysis for DMD, FKRP, ISPD, TMEM5, GTDC2, B3GALNT2, SGK196, LMNA, SEPN1, GAA, COL6A1, COL6A2, COL6A3\n","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e29cdfa1-4f16-4989-bbe8-e8b60c86210e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/7b8c830b-724c-45f3-919b-e2b3c6d5fcee_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a718bb6c-5337-4cac-abfd-0c6a2e379fa5","type":"EvidenceLine","dc:description":"recurrent missense, no functional data","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a718bb6c-5337-4cac-abfd-0c6a2e379fa5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in EGF12cb domain; Recurrent, shared haplotype (2 families); Revel 0.87\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/a718bb6c-5337-4cac-abfd-0c6a2e379fa5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/90e8fa83-3e83-4df7-94f5-1980fa30342d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.2044C>T (p.Pro682Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7385747"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/7b8c830b-724c-45f3-919b-e2b3c6d5fcee","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family UAE, individual II.1 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":22,"allele":{"id":"https://genegraph.clinicalgenome.org/r/90e8fa83-3e83-4df7-94f5-1980fa30342d"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Young adult onset, slow progression, mild neck weakness, scoliosis, rigid spine/neck, 75-80% FVC, normal CK, normal EMG\n","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a718bb6c-5337-4cac-abfd-0c6a2e379fa5_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/19c12833-54fd-4b2f-bc00-da029bbed369_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6fbc07ca-eb3a-4154-8931-546b47fb1588","type":"EvidenceLine","dc:description":"predicted null","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6fbc07ca-eb3a-4154-8931-546b47fb1588_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"NMD expected","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/6fbc07ca-eb3a-4154-8931-546b47fb1588_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/e427b456-0cb1-4ed0-8a7c-28f2d0d6ab29","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.1245_1246del (p.Trp415CysfsTer11)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695219896"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/fb172a0c-7464-4924-9c30-a4bfabdafd33","type":"EvidenceLine","dc:description":"predicted null","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb172a0c-7464-4924-9c30-a4bfabdafd33_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"NMD expected","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/fb172a0c-7464-4924-9c30-a4bfabdafd33_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/8ed1bd07-b86b-45bd-bba4-d9fc40378676","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.493C>T (p.Arg165Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7386424"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/19c12833-54fd-4b2f-bc00-da029bbed369","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family US3, individual II.2 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":5,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/8ed1bd07-b86b-45bd-bba4-d9fc40378676"},{"id":"https://genegraph.clinicalgenome.org/r/e427b456-0cb1-4ed0-8a7c-28f2d0d6ab29"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Infant onset, stable progression, severe neck weakness, speech delay, normal CK, myopathic EMG, dystrophic muscle biopsy\n","previousTesting":false,"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/fb172a0c-7464-4924-9c30-a4bfabdafd33_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/6fbc07ca-eb3a-4154-8931-546b47fb1588_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/84d870e4-3964-415a-b5a4-1c4399f1c1ca_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a833069d-3cb0-4be6-af88-40ec3dadfd11","type":"EvidenceLine","dc:description":"recurrent missense, no functional data","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a833069d-3cb0-4be6-af88-40ec3dadfd11_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in EGF12cb domain; recurrent, shared haplotype (2 families); Revel 0.87\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/a833069d-3cb0-4be6-af88-40ec3dadfd11_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/90e8fa83-3e83-4df7-94f5-1980fa30342d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/84d870e4-3964-415a-b5a4-1c4399f1c1ca","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family UK, individual II.1 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":35,"allele":{"id":"https://genegraph.clinicalgenome.org/r/90e8fa83-3e83-4df7-94f5-1980fa30342d"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Childhood onset, slow progression, ptosis, mild neck weakness, scoliosis, 75-80% FVC, normal CK, normal EMG\n","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a833069d-3cb0-4be6-af88-40ec3dadfd11_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/7bdc02d2-d632-4c7c-a8cb-ed4c265006fe_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e0fcad2-2f4a-4c4c-8105-c39430b16f24","type":"EvidenceLine","dc:description":"-0.5 for predicted null but altered protein product expected\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e0fcad2-2f4a-4c4c-8105-c39430b16f24_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"NMD not expected (frameshift for 188 aa, extension by 134 aa); expected to disrupt transmembrane domain","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/8e0fcad2-2f4a-4c4c-8105-c39430b16f24_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/ebf62744-5105-4455-98b3-dbf825ca2106","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.3143_3147dup (p.Val1050ProfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695219924"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/32c294ed-9051-463f-b969-6a564c038b8d","type":"EvidenceLine","dc:description":"inframe deletion of single residue, no functional data","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/32c294ed-9051-463f-b969-6a564c038b8d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in EGF12cb domain ","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/32c294ed-9051-463f-b969-6a564c038b8d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/cf2b7440-8f08-42e3-bce9-38973ea4e588","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.2105_2107del (p.Asp702del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695219925"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7bdc02d2-d632-4c7c-a8cb-ed4c265006fe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family UK2, individual II.1 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":21,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/cf2b7440-8f08-42e3-bce9-38973ea4e588"},{"id":"https://genegraph.clinicalgenome.org/r/ebf62744-5105-4455-98b3-dbf825ca2106"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Early childhood onset, rapid progression, loss of ambulation at 8 years, contractures, mild neck weakness, mild scoliosis, rigid spine, autism spectrum disorder\n","previousTesting":false,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8e0fcad2-2f4a-4c4c-8105-c39430b16f24_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/32c294ed-9051-463f-b969-6a564c038b8d_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.1},{"id":"https://genegraph.clinicalgenome.org/r/ddf77182-44e3-4c88-a48f-5d89a8e46273_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5acb5d42-08b4-4a5f-bc29-c3067af71fd3","type":"EvidenceLine","dc:description":"recurrent missense, no functional data","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5acb5d42-08b4-4a5f-bc29-c3067af71fd3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in EGF16cb domain; recurrent, at least 2 haplotypes (3 families); Revel 0.92\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/5acb5d42-08b4-4a5f-bc29-c3067af71fd3_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/ddf77182-44e3-4c88-a48f-5d89a8e46273"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/61b392e7-cee2-493a-9b97-9a607d0bb58c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf5482d3-d1b3-4ef0-8040-5c65cd75910e","type":"EvidenceLine","dc:description":"recurrent missense, no functional data\nin trans to 3.2 Mb 14q32.33 terminal deletion that affects 61 genes, including all of JAG2 (deletion not scored)\n","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf5482d3-d1b3-4ef0-8040-5c65cd75910e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in EGF16cb domain; recurrent, at least 2 haplotypes (3 families); Revel 0.92\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/cf5482d3-d1b3-4ef0-8040-5c65cd75910e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/1be6710f-f84d-4445-ab32-b841a1808d6e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/61b392e7-cee2-493a-9b97-9a607d0bb58c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family US1, individual II.1 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":41,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1be6710f-f84d-4445-ab32-b841a1808d6e"},"detectionMethod":"terminal deletion also observed on FISH","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Childhood onset, slow progression, contractures, generalized muscle atrophy, mild facial weakness, ptosis, mild neck weakness, scoliosis, rigid spine, speech delay, CK 4xULN, myopathic EMG, dystrophic muscle biopsy\n","previousTesting":false,"secondTestingMethod":"Other","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cf5482d3-d1b3-4ef0-8040-5c65cd75910e_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/9e5ad674-df72-49d6-8114-c4401f69e7e0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63afc09c-1019-407b-ad26-d9943f179aa3","type":"EvidenceLine","dc:description":"missense, no functional data","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63afc09c-1019-407b-ad26-d9943f179aa3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in EGF14 domain; Revel 0.72\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/63afc09c-1019-407b-ad26-d9943f179aa3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39121631","allele":{"id":"https://genegraph.clinicalgenome.org/r/7db5072c-3c96-40ae-9ced-1d455f0d1ba1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.2350C>T (p.Arg784Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391267419"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/46bb0219-9d1f-476a-9dd8-f1833f3722fc","type":"EvidenceLine","dc:description":"missense, no functional data","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46bb0219-9d1f-476a-9dd8-f1833f3722fc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in DSL domain; protein destabilization predicted by structural modeling; Revel 0.84\n\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/46bb0219-9d1f-476a-9dd8-f1833f3722fc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39121631","allele":{"id":"https://genegraph.clinicalgenome.org/r/499478f3-d692-46f4-9e7d-9ee40f502d65","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.703T>C (p.Trp235Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391275810"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/9e5ad674-df72-49d6-8114-c4401f69e7e0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39121631","rdfs:label":"Dofash 2024 Family 2, individual II:1 ","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/7db5072c-3c96-40ae-9ced-1d455f0d1ba1"},{"id":"https://genegraph.clinicalgenome.org/r/499478f3-d692-46f4-9e7d-9ee40f502d65"}],"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Rapidly progressive limb weakness, mildly elevated serum CK, diffuse muscle atrophy and fat infiltration on muscle MRI, myopathic muscle biopsy\n","previousTesting":false,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/63afc09c-1019-407b-ad26-d9943f179aa3_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/46bb0219-9d1f-476a-9dd8-f1833f3722fc_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/5a3c83dd-1d6c-49bf-9e29-486adfd58c3b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8cd9a730-8c98-41a5-8db1-89a746b5f165","type":"EvidenceLine","dc:description":"missense, no functional data","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8cd9a730-8c98-41a5-8db1-89a746b5f165_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"not in a domain; Revel 0.52","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/8cd9a730-8c98-41a5-8db1-89a746b5f165_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/a96df8b3-8385-4db8-9018-d4ce8b8758a8"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/5a3c83dd-1d6c-49bf-9e29-486adfd58c3b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family FRA, individual II.1 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":22,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a96df8b3-8385-4db8-9018-d4ce8b8758a8"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Childhood onset, rapid progression, loss of ambulation at 14 years, contractures, generalized muscle atrophy, moderate neck weakness, scoliosis, rigid spine, 55% FVC, mild ID, normal CK, myopathic EMG, dystrophic muscle biopsy\n","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8cd9a730-8c98-41a5-8db1-89a746b5f165_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/513045c7-102a-45c3-9d14-67a0afeda6c0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8f1d60f5-3778-4119-aa8d-7b120b5d278b","type":"EvidenceLine","dc:description":"missense, no functional data","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8f1d60f5-3778-4119-aa8d-7b120b5d278b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in EGF4 domain; Revel 0.79\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/8f1d60f5-3778-4119-aa8d-7b120b5d278b_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/513045c7-102a-45c3-9d14-67a0afeda6c0"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/7a6474d5-cf81-4c4a-b98b-6f307c5f409e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/775353af-68e2-4ecc-9aee-918f8c78d822","type":"EvidenceLine","dc:description":"missense, no functional data","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/775353af-68e2-4ecc-9aee-918f8c78d822_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in C2 domain; Revel 0.61","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/775353af-68e2-4ecc-9aee-918f8c78d822_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/cfe4d3c5-f6fa-4eb7-adeb-a3e09f13d0de","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.283A>G (p.Thr95Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391173533"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/bd7f6b5e-5272-43fe-86e0-e6db98f999e4","type":"EvidenceLine","dc:description":"missense, no functional data","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd7f6b5e-5272-43fe-86e0-e6db98f999e4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in EGF15cb domain; Revel 0.68","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/bd7f6b5e-5272-43fe-86e0-e6db98f999e4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/1f74537e-6fb9-4f56-8c28-6653d192f9dc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.2473C>T (p.Arg825Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391267120"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/7a6474d5-cf81-4c4a-b98b-6f307c5f409e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family EST, individual II.1 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":11,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/cfe4d3c5-f6fa-4eb7-adeb-a3e09f13d0de"},{"id":"https://genegraph.clinicalgenome.org/r/1f74537e-6fb9-4f56-8c28-6653d192f9dc"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Childhood onset, slow progression, contractures, mild neck weakness, CK 1.5xULN, myopathic EMG, dystrophic muscle biopsy, non-significant mitral valve prolapse","previousTesting":false,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/bd7f6b5e-5272-43fe-86e0-e6db98f999e4_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/775353af-68e2-4ecc-9aee-918f8c78d822_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/6a9d87de-d611-49f6-8c8f-ac3674d189ee_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a88fa10-9dda-40a7-8339-0ea525c6945b","type":"EvidenceLine","dc:description":"missense, no functional data","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a88fa10-9dda-40a7-8339-0ea525c6945b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"located in C2 domain; protein destabilization predicted by structural modeling; Revel 0.53\n","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/4a88fa10-9dda-40a7-8339-0ea525c6945b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","allele":{"id":"https://genegraph.clinicalgenome.org/r/7d81fd3a-865f-41f7-ba24-94f6d240a776","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_002226.5(JAG2):c.490G>A (p.Glu164Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391276684"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/6a9d87de-d611-49f6-8c8f-ac3674d189ee","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Family IRA, individual II.1 ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/7d81fd3a-865f-41f7-ba24-94f6d240a776"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Infant onset, rapid progression, loss of ambulation at 5 years, contractures, mild neck weakness, scoliosis, normal CK, myopathic EMG, dystrophic muscle biopsy\n","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4a88fa10-9dda-40a7-8339-0ea525c6945b_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":8.6},{"id":"https://genegraph.clinicalgenome.org/r/16f43ce9-05b5-437d-a35e-b1c379c0ba7a_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16f43ce9-05b5-437d-a35e-b1c379c0ba7a_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ff7cefa6-49e8-49a4-8c73-a7afc35fb2e8","type":"EvidenceLine","dc:description":"No phenotype overlapping muscular dystrophy observed in Drosophila with RNAi-mediated knockdown of JAG2 in muscle cells. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3778ef15-412c-4701-80a0-7d7c7cefdb75","type":"Finding","dc:description":"RNAi against Ser (Serrate, the Drosophila ortholog of JAG2) was targeted to muscle cells by crossing the muscle-specific Mef2-GAL4 driver to UAS-IR transgenic RNAi lines. Progeny from these crosses were assayed for viability, posture, locomotion and flight. Flies that express a Ser-RNAi construct in muscle cells show a wildtype phenotype. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20220848","rdfs:label":"Schnorrer 2010 Drosophila model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c09c09b0-4702-4a7c-aa4b-2eb1d54abba6","type":"EvidenceLine","dc:description":"Insufficient overlap with human phenotype.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b419d0a-7cc0-4e47-8dde-19e37bd5be9d","type":"Finding","dc:description":"Homozygous knockout mice created via deletion of the DSL domain, which is required for receptor interactions. Homozygous mice: die at birth due to cleft palate and breathing difficulty; exhibit syndactyly of fore- and hindlimbs; have a hyperplastic apical ectodermal ridge (AER) and altered gene expression in the AER and ZPA (zone of polarizing activity), including of Fgf8, Shh, Bmp2, Bmp4, and Bmp7.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9531541","rdfs:label":"Jiang 1998 knockout mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/fc7d893e-830b-4379-8967-c9d6b7ed2d92","type":"EvidenceLine","dc:description":"Age-related decline in locomotor activity overlaps with variable onset and progressive muscular dystrophy and corresponding decline in motor function observed in human patients. However, this model was not a direct manipulation of JAG2; instead, it involved indirect downregulation of JAG2-mediated trans Notch signaling in a subset of cells, which is not a very good model of the JAG2 sequence variants observed in human patients. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf917cc1-4f77-4415-a820-24a4de81cd9c","type":"Finding","dc:description":"Generated transgenic Drosophila that express a drpr-RNAi construct in the discrete and well-characterized subset of Ser-positive cells located in the wing imaginal disc. (Serrate (Ser) = Drosophila ortholog of JAG2. Drpr = ortholog of MEGF10.) Ser expressed in these epithelial cells is known to activate Notch in the closely opposed adult muscle progenitors. Flies with downregulated Drpr in Ser-positive cells displayed a marked decline in locomotor activity with age (versus corresponding age-matched controls), as assessed in a negative geotaxis assay. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Drosophila model ","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/16f43ce9-05b5-437d-a35e-b1c379c0ba7a_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d547075e-9012-4e8d-9ffa-131ae75ac056","type":"EvidenceLine","dc:description":"Consistent with similar alterations in Notch pathway gene expression observed in patient skeletal muscle tissue by Coppens et al. (2021). Scored in conjunction with those data.  ","calculatedScore":1,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84295e54-d27d-418b-bbb4-f73a3f6522d1","type":"FunctionalAlteration","dc:description":"RNAseq of skeletal muscle tissue from a patient homozygous for c.1021G>T p.(Gly341Cys) showed down-regulated expression of PAX7, MYF5, and MEGF10, which are critical for myogenesis.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/39121631","rdfs:label":"Dofash 2024 Notch gene expression in patient cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/d4bf091a-4530-47b1-ad46-5396557444ba","type":"EvidenceLine","dc:description":"Consistent with similar alterations in Notch pathway gene expression observed in non-patient cells following JAG2 knockdown, but no demonstrated link between gene expression changes and clinical muscular dystrophy phenotype. ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11ddd1fa-a25c-442e-b337-7f7dd800586e","type":"FunctionalAlteration","dc:description":"RNAseq was performed on skeletal muscle tissue from 2 patients. Patient EST II.1 had compound heterozygous c.283A>G p.(Thr95Ala) and c.2473C>T p.(Arg825Cys), while patient US1 II.1 had compound heterozygous c.2515G>A p.(Gly839Arg) and a 3.2 Mb 14q32.33 terminal deletion encompassing JAG2. In EST II.1, PAX7 and MYF5 expression was significantly downregulated, whereas that of CADM2 was significantly upregulated. In US1 II.1, PACS2 expression was significantly downregulated. PAX7 expression was also reduced, but the reduction did not reach statistical significance. \n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Notch gene expression in patient cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/30a57bf6-6e0e-4a62-b9d5-07c4b9dd16fe","type":"EvidenceLine","dc:description":"Consistent with similar alterations in Notch pathway gene expression observed in patient skeletal muscle tissue, but no demonstrated link between gene expression changes and clinical muscular dystrophy phenotype.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33f5fca7-568b-4b95-aa76-13016b0e0b57","type":"FunctionalAlteration","dc:description":"Array qPCR gene expression analysis was conducted following shRNA-mediated knockdown of Jag2 (by 70%) in murine myoblasts (C2C12 cells). An ~53% reduction in Megf10 expression (reduced Megf10 expression also observed in patient cells) was observed. No significant change in Notch1 expression was found. There was also significantly downregulated expression in 22 of 75 measured Notch pathway genes.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 Notch gene expression in knockdown cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/16f43ce9-05b5-437d-a35e-b1c379c0ba7a_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/81312302-0c31-484b-aabf-7ce6c36d4e00","type":"EvidenceLine","dc:description":"Limited phenotype overlap, and Notch signaling involves many genes and is involved in a wide range of processes.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05a48c8d-2dd7-4061-adda-e4f198e24913","type":"Finding","dc:description":"JAG2 is involved in Notch signaling; other genes involved in Notch signaling have been associated with disease but lacking strong phenotype overlap with a primarily muscular dystrophy phenotype. Disease associations of the 3 other canonical activating ligands include Dll1: DLL1-associated neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures (NEDBAS); Dll4: Adams-Oliver syndrome; and Jag1: Alagille syndrome, Charcot-Marie-Tooth disease, tetralogy of Fallot, deafness, congenital heart defects, and posterior embryotoxon. The predominantly inhibitory ligand, Dll3, is associated with spondylocostal dysostosis. Disease associations of the 4 Notch receptors include Notch1: Adams Oliver syndrome; Notch2: Alagille syndrome, Hajdu-Cheney syndrome; Notch3: cerebral arteriopathy with subcortical infarcts and leukoencephalopathy; and Notch4: currently no association.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33861953","rdfs:label":"Coppens 2021 function in Notch signaling","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1}],"evidenceStrength":"Moderate","sequence":8883,"specifiedBy":"GeneValidityCriteria10","strengthScore":9.6,"subject":{"id":"https://genegraph.clinicalgenome.org/r/4R0qXL6SgWU","type":"GeneValidityProposition","disease":"obo:MONDO_0015152","gene":"hgnc:6189","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_16f43ce9-05b5-437d-a35e-b1c379c0ba7a-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}